| LncRNA |
Compound |
Cancer |
P-value |
Effect |
| ENSG00000258561.1 |
Ponatinib |
Cervical squamouscell carcinoma and endocervical adenocarcinoma |
0.001873695 |
Resistant |
| ENSG00000258561.1 |
Ponatinib |
Brain lower grade glioma |
0.00705547 |
Resistant |
| ENSG00000258561.1 |
Ponatinib |
Lymphoid neoplasm diffuse large B-cell lymphoma |
0.041917947 |
Resistant |
